Orbimed Advisors LLC Biogen Inc. Transaction History

Orbimed Advisors LLC

$4.24 Billion
Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 813,000 shares of BIIB stock, worth $121 Million. This represents 3.71% of its overall portfolio holdings.

Number of Shares

813,000

Previous 900,900 9.76%

Holding current value

$121 Million

Previous $209 Million 24.54%

% of portfolio

3.71%

Previous 5.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $16.6 Million - $20.8 Million	-87,900 Reduced 9.76%	813,000 $158 Million
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $15.5 Million - $19.6 Million	73,300 Added 8.86%	900,900 $194 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $60.3 Million - $72.6 Million	270,800 Added 48.64%	827,600 $214 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $14.3 Million - $16.5 Million	51,800 Added 10.26%	556,800 $159 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $63.3 Million - $72.1 Million	246,800 Added 95.58%	505,000 $140 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $8.48 Million - $10.3 Million	33,600 Added 14.96%	258,200 $71.5 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $22 Million - $30.3 Million	113,000 Added 101.25%	224,600 $60 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1.18 Million - $1.41 Million	-6,300 Reduced 5.34%	111,600 $22.8 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $21.8 Million - $27.4 Million	-112,300 Reduced 48.78%	117,900 $24.8 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $895,680 - $1.15 Million	-4,000 Reduced 1.71%	230,200 $55.2 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $47.2 Million - $61.6 Million	166,800 Added 247.48%	234,200 $66.3 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.78 Million - $6.05 Million	-14,600 Reduced 17.8%	67,400 $23.3 Million
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $109 Million - $127 Million	-447,400 Reduced 84.51%	82,000 $22.9 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $44.1 Million - $66.3 Million	-186,500 Reduced 26.05%	529,400 $130 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $60.9 Million - $80.7 Million	235,500 Added 49.02%	715,900 $192 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $112 Million - $142 Million	415,900 Added 644.81%	480,400 $152 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $6.23 Million - $8.61 Million	28,300 Added 78.18%	64,500 $19.1 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $11.2 Million - $12.6 Million	-51,500 Reduced 58.72%	36,200 $8.43 Million
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $162 Million - $253 Million	-747,549 Reduced 89.5%	87,700 $20.7 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $20.9 Million - $26.5 Million	-75,051 Reduced 8.24%	835,249 $251 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $75.6 Million - $98.9 Million	-257,600 Reduced 22.06%	910,300 $322 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $32.8 Million - $39.1 Million	127,500 Added 12.25%	1,167,900 $339 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $49.5 Million - $70 Million	-190,300 Reduced 15.46%	1,040,400 $285 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $123 Million - $138 Million	-399,300 Reduced 24.5%	1,230,700 $392 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $458 Million - $537 Million	1,630,000	1,630,000 $510 Million

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account

Orbimed Advisors LLC Biogen Inc. Transaction History